Zai Lab Announces Upcoming Participation in the BofA Securities 2020 Health Care Conference Read more about Zai Lab Announces Upcoming Participation in the BofA Securities 2020 Health Care Conference
Dr. Ning Xu selected as DIA Fellow Class of 2020 Read more about Dr. Ning Xu selected as DIA Fellow Class of 2020
Zai Lab Announces China’s NMPA Grants Priority Review to the sNDA for ZEJULA (Niraparib) for First-Line Ovarian Cancer Maintenance Treatment Read more about Zai Lab Announces China’s NMPA Grants Priority Review to the sNDA for ZEJULA (Niraparib) for First-Line Ovarian Cancer Maintenance Treatment
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) Read more about Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)
Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates Read more about Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates
Zai Lab Announces Acceptance of sNDA Submission of ZEJULA® (Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China by the NMPA Read more about Zai Lab Announces Acceptance of sNDA Submission of ZEJULA® (Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China by the NMPA
Zai Lab to Announce Financial Results for the Full Year Ended December 31, 2019 and Corporate Updates on March 19, 2020 Read more about Zai Lab to Announce Financial Results for the Full Year Ended December 31, 2019 and Corporate Updates on March 19, 2020
ZEJULA® included in Tencent’s Private Insurance Read more about ZEJULA® included in Tencent’s Private Insurance
Zai Lab Donates RMB 1 Million to coronavirus relief efforts in Hubei Province Read more about Zai Lab Donates RMB 1 Million to coronavirus relief efforts in Hubei Province
Zai Lab Announces Upcoming Participation at February Conferences Read more about Zai Lab Announces Upcoming Participation at February Conferences